28 March 2026 : Database Analysis
Anoikis-Related Genes Signature Contributes to Predicting Prognosis and Response to Immunotherapy in Lung Squamous Cell Carcinoma
Hongjun Lu BCE 1, Wei Huang ADE 1, Qiurong Shen DEF 1, Rongxing Liu ADEF 1*DOI: 10.12659/MSM.951722
Med Sci Monit 2026; 32:e951722
Table 1 General clinical characteristics of patients.
| Characteristics | TCGA (LUSC) | GSE33479 | GSE12472 |
|---|---|---|---|
| Number of patients | 178 | 108 | 35 |
| Sex | Male: 131Female: 47 | Male: 86Female: 22 | Male: 32Female: 3 |
| Age at surgery | Mean: 68 years | Mean: 62 years | Mean: 65 years |
| Smoking status | Never smoker: 7;Former smoker >15 years: 50;Former smoker ≤5 years: 87;Current smoker: 28;N/A: 6 | Former smokers: 49;Current smokers: 59 | Current smoker: 19;Former smoker: 15;N/A: 1 |
| Tumor stage | I: 97; II: 38;III: 38; IV: 3;N/A: 2T1: 35; T2: 116;T3: 14; T4: 12;N/A: 1N0: 117; N1: 39;N2: 17; N3: 5 | Not applicable | T1: 2;T2: 27;T3: 6Metastases: None: 15 Lymph nodes: 9 Distant: 12 |
| Histology grade | Not applicable | Normal: 13;Hyperplasia: 15;Metaplasia: 15;Mild dysplasia: 13;Moderate dysplasia: 13;Severe dysplasia: 12;Carcinoma in situ: 13;Squamous cell carcinoma: 14 | Not applicable |